Fmoc Amino Acids

<p>Fmoc-Tyr-OH is a peptide that can be used as an agent for the treatment of epidermal growth factor receptor (EGFR) related diseases. It has been shown to be effective in inhibiting the replication of RNA and DNA, which may contribute to the inhibition of tumor growth. Fmoc-Tyr-OH is synthesized through solid phase synthesis where it is reacted with trifluoroacetic acid and particle. This reaction is enhanced by adding an iodination reaction and phosphatase. The polymerase chain reaction then occurs in order to produce more Fmoc-Tyr-OH peptides. Fmoc-Tyr-OH also has a high affinity for acidic ph, making it suitable for use in acidic environments such as tumors.</p>

<p>N-alpha-Fmoc-Nepsilon-dansyl-L-lysine is a fluorescent molecule that is synthesized by attaching an allyl group to the amino acid lysine. This fluorescence can be used as a probe for specific interactions with proteins. N-alpha-Fmoc-Nepsilon-dansyl-L-lysine has been shown to interact with copolymers of poly(ethylene glycol) and poly(allylamine). The interaction results in a supramolecular, or self assembling, structure. The molecule's fluorescence can be activated by irradiation and this makes it useful for studying protein target binding.</p>

<p>Fmoc-Trp(5-OH)-OH is a molecule that has been shown to have anticancer activity. It inhibits the proliferation of cancer cells and inhibits the production of fatty acids. It also has antiinflammatory properties and inhibits the growth of bacteria by inhibiting chloride channels. Fmoc-Trp(5-OH)-OH has been shown to inhibit the binding of 4-methylumbelliferone (4MU) to human erythrocytes, which is an indicator of its capability as a coumarin derivative. Fmoc-Trp(5-OH)-OH has also been found to be effective against tuberculosis through hydrogen bond interactions with the enzyme mycobacterium tuberculosis DNA polymerase.</p>